OCT-angiography in Diabetic Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-07-31

Study Completion Date

2018-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Around the world there is an increasing incidence of diabetes mellitus, with millions of people affected. In this population, diabetic macular edema (DME) is the most common cause of visual impairment. While the visual impairment caused by EMD is variable, its early treatment can improve visual acuity and quality of life. The objective of this project is to use the new OCT-angiography technology, which evaluates macular capillary network without the need of intravenous injection of contrast, to assess macular microcirculatory network in its response to intravitreal pharmacological treatment of EMD. The resulting qualitative evaluation can be helpful in understanding the pathophysiology of visual loss associated with DME and in determining prognosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Home Monitoring of Diabetic Macular Edema

NCT05223569

Macular Edema Due to Diabetes Mellitus

UNKNOWN NA

A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema

NCT02876393

Diabetes Mellitus Diabetic Retinopathy Diabetic Macular Edema

COMPLETED

Contrast Sensitivity and Diabetic Macular Edema

NCT02217306

DIABETES MELLITUS DIABETIC RETINOPATHY MACULAR EDEMA

COMPLETED

Imaging Parameters and DME Treatment Response

NCT02637245

Diabetic Macular Edema Diabetic Retinopathy

COMPLETED

Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes

NCT07270133

Diabetic Retinal Disease

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients who participate in this study will be selected among adults treated at the Retina Clinic and Ocular Oftalmologia clinics and will be aware of all stages of the research, formalizing the approval of their participation by informed consent term. The tests will be performed after pupillary dilation with 2 eye drops of tropicamide 1% (Mydriacyl, Alcon Laboratories), in Cirrus 5000 HD-OCT devices (Carl Zeiss Meditec - Dublin USA). Image acquisition protocols Optic Disc Cube 200x200 and 512x128 Macular Cube will be used, with analysis by RNFL protocols and NGO Analysis Report and Macular Cube Analysis Report, respectively. Subjective analysis of the examinations will be performed by the three authors of this project independently and then compared between them.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Macular Edema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Previous diagnosis of diabetes mellitus type 1 or 2;
* Age equal or greater than 18 years;
* At least one eye with diabetic macular edema and central thickness greater than or equal to 290 microns (female patients) or 305 microns (males) measured by OCT and subjected to intravitreal pharmacotherapy.

Exclusion Criteria

* Aphakic patients;
* History of major eye surgeries (vitrectomy, cataract surgery, scleral buckle, other intraocular surgery) in the last 4 months;
* Tractional retinal detachment involving the macula, vitreomacular traction syndrome or other concurrent macular diseases;
* Advanced or uncontrolled glaucoma (according to the investigator's judgment); Evidence of angle neovascularization;
* Presence of an eye condition (besides diabetic retinopathy) which, in the opinion of the investigator, may alter the visual acuity during the study course (e.g. venous or arterial retinal occlusions, uveitis or other ocular inflammatory diseases, neovascular glaucoma, etc.);
* Significative cataract which, in the opinion of the investigator, may be decreasing visual acuity in 3 lines or more;
* History of YAG Laser capsulotomy in the last 2 months;
* Severe renal disease, defined as chronic renal failure requiring dialysis or a kidney transplant;
* Blood pressure higher than 180/110 mmHg, acute myocardial infarction, other acute cardiac events requiring hospitalisation, stroke, transient ischemic attack or treatment for congestive heart failure;
* Systemic treatment with anti-VEGF or pro-VEGF in the last 4 months.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes